Trial Profile
A randomised phase II study of a loading dose of ibandronate [ibandronic acid] schedules in patients with bone metastases from breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary) ; Ibandronic acid
- Indications Advanced breast cancer; Bone metastases
- Focus Biomarker; Pharmacodynamics
- Sponsors Roche
- 13 Dec 2005 New trial record.